We are a team of uniquely combined specialists in the areas of psychiatry, data analytics, IT solutions and business development that tackle the big problem of severe mental health disease management.
Our mission is to help patients, their carers and doctors better understand mental health disorders and help them live stable lives.
We Are Mindpax
Mindpax is a leading digital therapeutics tools company tackling bipolar disorder. We focus on improving the clinical conditions and quality of life of bipolar patients. To achieve that, we use a combination of long-term symptom monitoring and targeted psychoeducation.
Mindpax seeks DiGa listing and FDA Breakthrough Device designation.
Validation study begins
Start of a validation study in the Czech republic to confirm the efficacy of Mindpax Digital Therapeutics
Collaboration with industry partners
Mindpax system is used in clinical studies with pharma and research institutions around the globe.
A full version of the Mindpax system is launched
2021
Mindpax M1 with clinically relevant feedback is launched
2020
Mindpax start ADHD feasibility study
Mindpax receives Class One notification from SÚKL State Institute for Drug Control of the Czech Republic
2019
Mindpax starts collaborating with sports teams and Armed Forces
2018
Aktibipo400 Clinical Study starts
2017
Mindpax M0 with Data Collection Launched
2016
Mindpax Founded in Prague, Czech Republic
2015
Clinical Partners
Business Partners
Recognitions
HEALTH-i award winner 2018
Eit Health European Health Catapult German Winner and European Finalist 2018
BayStartUP Startup
Demo Nights Munich
BIOVaria Startup Pitch and Partners - Raising StartUp Award
Mindpax in numbers
1000+
Users
20+
Clinical Partners
Largest
Bipolar Disorder Dataset
5
Clinical Publications
Contact Us
If you are interested in our vision and thinking about getting involved yourself, your loved one or investing in a meaningful project do not hesitate to contact us.